The aim of the study was to investigate whether weight loss followed the same pattern in HCV patients
Keywords
HCV
interferon
weight loss
surrogate markers
Metrics
DOI is not available
Weight loss in HCV patients can be used as a surrogate marker for evaluation of interferon (IFN-?) treatment efficacy - A prospective pilot study | PJPS